Wang, K., Li, Z., Xuan, Y., Zhao, Y., Deng, C., Wang, M., . . . Mei, J. (2023). Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes. BMC.
Citace podle Chicago (17th ed.)Wang, Kewei, et al. Pan-cancer Analysis of NFE2L2 Mutations Identifies a Subset of Lung Cancers with Distinct Genomic and Improved Immunotherapy Outcomes. BMC, 2023.
Citace podle MLA (9th ed.)Wang, Kewei, et al. Pan-cancer Analysis of NFE2L2 Mutations Identifies a Subset of Lung Cancers with Distinct Genomic and Improved Immunotherapy Outcomes. BMC, 2023.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..